Abstract:BACKGROUND: Inflammatory responses in injured nerves have been recognized as important factors for initially sensitizing nociceptive neurons. Cyclooxygenase (COX) is the rate-limiting enzyme in prostaglandin synthesis, and COX-2 inhibitor is involved in mechanisms of analgesia and anti-inflammation.OBJECTIVE: To investigate the effects of COX-2 inhibitor on thermal and mechanical hyperalgesia, as well as expression of growth associated protein 43 (GAP-43) and nerve growth factor (NGF) in dorsal root ganglion, in a rat model of neuropathic pain due to chronic constriction injury.DESIGN, TIME AND SETTING: A randomized, controlled, comparison study that was performed at the Surgical Department and Pathological Laboratory, Second Affiliated Hospital of Shantou University Medical College from September 2006 to September 2007.MATERIALS: COX-2 inhibitor, lornoxicam, was purchased from Nycomed Pharmaceutical (Austria); rabbit anti-GAP-43, and rabbit anti-NGF polyclonal antibodies were purchased from Boster, Wuhan, China.METHODS: A total of 50 adult, Wistar rats were randomly assigned to four groups: normal control (n = 5), model (n = 15), normal saline control (n = 15), and lornoxicam treatment (n = 15). With exception of the control group, the sciatic nerve of all rats was loosely ligated to establish a model of chronic constriction injury. The model rats were divided into three subgroups according to varying post-operative survival periods: 3, 7 and 14 days (n = 5), respectively. Rats in the lornoxicam treatment group were intraperitoneally injected with 1.3 mg/kg lornoxicam every 12 hours throughout the entire experimental procedure. Rats in the normal saline control group were intraperitoneally injected with 1.3 mL/kg saline.MAIN OUTCOME MEASURES: Immunohistochemistry revealed expression of GAP-43 and NGF in the L5 dorsal root ganglions. Mechanical withdrawal threshold and thermal withdrawal latency were used to observe neurological behavioral changes in rats.RESULTS: The relative gray values of GAP-43- and NGF-positive neurons in the model group were remarkably increased compared with the normal control rats (P < 0.01), while the relative gray values in the lomoxicam treatment group were significantly less than the model and normal saline control groups (P < 0.01). Mechanical withdrawal threshold and thermal withdrawal latency gradually decreased with increasing injury time in the model, normal saline control, and lornoxicam treatment groups, and were significantly less than the normal control group (P < 0.05). In addition, mechanical withdrawal threshold and thermal Withdrawal latency were significantly greater in the lornoxicam treatment group compared with the model and normal saline control groups (P < 0.05).CONCLUSION: Intraperitoneal injection of the COX-2 inhibitor lornoxicam attenuated mechanical and thermal hyperalgesia induced by sciatic nerve chronic constriction injury and inhibited the increased expression of GAP-43 and NGF.

Effect of intrathecal morphine on cyclooxygenase-2 expression in dorsal horn of spinal cord in a rat model of peripheral pain

Effects of Intrathecal Morphine on Excitatory Amino Acid Contents of Spinal Cord in a Rat Model of Incision Pain

Effect of intraperitoneal injection of Lidocaine on expression of NMDAR1 in spinal dorsal horn of a rat model of incisional pain

[Effect of Intrathecal Pumping Morphine on Immunological Function in Rats with Formalin Pain].

Effect of intrathecal injection of morphine and ketamine on spinal excitatory amino acid content and glutamate transporter subtype-1 mRNA expression in rat model of incision pain

Effect of intrathecal injection of morphine and baclofen on contents of spinal excitatory amino acids in rat model of incisional pain

[Effect of Morphine on Dorsal Horn Projection Neurons in Neuropathic Pain Rats].

[Changes in Expression of Cyclooxygenase-2 in the Spinal Dorsal Horn after Intrathecal P38mapk Inhibitor SB203580 on Neuropathic Pain in Rats].

Effect of Intrathecal Sufentanil and Protein Kinase C Inhibitor on Pain Threshold and the Expression of NMDA Receptor/cgrp in Spinal Dorsal Horn in Rats with Neuropathic Pain

Effect of intrathecal δ-opioid receptor antagonists specificity on morphine tolerance in rats with chronic pain

Changes in Expression of Purinergic P2X4 Receptor in Spinal Cord Dorsal Horn and Dorsal Root Ganglion in a Rat Model of Acute Morphine Tolerance or Inflammatory Pain

Effect of Intrathecal Katemine on the Expression of Nnos in Spinal Dorsal Horn in Rats with Formalin Pain

Effect of Intrathecal Sufentanil on NMDAR and CGRP Expression in Dorsal Horn of Spinal Cord in a Rat Model of Neuropathic Pain

Effects of Cyclooxygenase 2 Inhibitor on Growth-Associated Protein 43 and Nerve Growth Factor Expression in Dorsal Root Ganglion During Neuropathic Pain Development

Effect of intrathecal PSD-93 AS ODN on rats with morphine tolerance

The role of monocarboxylate transporter-2 in the spinal dorsal horn in rat's persistent postoperative pain

Involvement of 5-hydroxytryptamine1A receptors in the descending anti-nociceptive pathway from periaqueductal gray to the spinal dorsal horn in intact rats, rats with nerve injury and rats with inflammation

Effects of Intrathecal Butorphanol on Rat's Pain Threshold and Changes of Neuronal NMDA Receptor Expression in Rat Spinal Dorsal Horn Following Spared Nerve Injury of Sciatic Nerve

Effect of Intrathecal Administration of a Mixture of Butorphanol and Ketamine on Camp-Pka-creb Signal Transduction Pathway in Spinal Dorsal Horn of Rats with Inflammatory Pain

Effects of group Ⅰ metabotropic glutamate receptor antagonist on thermal pain threshold in morphine tolerant rats

Effect of Compound K on Spinal Toll-like Receptor 4 Expression During Morphine-Induced Hyperalge-Sia in Rats